Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
Resource Type
Article
Authors
Brown, J William L ; Cunniffe, Nick G ; Prados, Ferran ; Kanber, Baris ; Jones, Joanne L ; Needham, Edward ; Georgieva, Zoya ; Rog, David ; Pearson, Owen R ; Overell, James ; MacManus, David ; Samson, Rebecca S ; Stutters, Jonathan ; ffrench-Constant, Charles ; Gandini Wheeler-Kingshott, Claudia A M ; Moran, Carla ; Flynn, Paul D ; Michell, Andrew W ; Franklin, Robin J M ; Chandran, Siddharthan ; Altmann, Daniel R ; Chard, Declan T ; Connick, Peter ; Coles, Alasdair J
Source
In The Lancet Neurology September 2021 20(9):709-720
Subject
Primary Research Articles
Language
ISSN
1474-4422